Citrate intermediates

Ultraftne LaFeOj is formed directly in the temperature range of 450-550 C by the decomposition of the mixed citrate. Intermediates such as La,Oj, Fe Oj have not been detected in the decomposition process. 

In studies of the polymerization kinetics of triaUyl citrate [6299-73-6] the cyclization constant was found to be intermediate between that of diaUyl succinate and DAP (86). Copolymerization reactivity ratios with vinyl monomers have been reported (87). At 60°C with benzoyl peroxide as initiator, triaUyl citrate retards polymerization of styrene, acrylonitrile, vinyl choloride, and vinyl acetate. Properties of polyfunctional aUyl esters are given in Table 7 some of these esters have sharp odors and cause skin irritation. 

Figure 1 illustrates the complexity of the Cr(III) ion in aqueous solutions. The relative strength of anion displacement of H2O for a select group of species follows the order perchlorate < nitrate < chloride < sulfate < formate < acetate < glycolate < tartrate < citrate < oxalate (12). It is also possible for any anion of this series to displace the anion before it, ie, citrate can displace a coordinated tartrate or sulfate anion. These displacement reactions are kineticaHy slow, however, and several intermediate and combination species are possible before equiUbrium is obtained. 

Citrate synthase catalyzes the metabolically important formation of citrate from ace-tyl-CoA and oxaloacetate [68]. Asp-375 (numbering for pig CS) has been shown to be the base for the rate-limiting deprotonation of acetyl-CoA (Fig. 5) [69]. An intennediate (which subsequently attacks the second substrate, oxaloacetate) is believed to be formed in this step the intermediate is thought to be stabilized by a hydrogen bond with His-274. It is uncertain from the experimental data whether this intermediate is the enolate or enol of acetyl-CoA related questions arise in several similar enzymatic reactions such as that catalyzed by triosephosphate isomerase. From the relative pK values of Asp-375... 

Glycolysis and the citric acid cycle (to be discussed in Chapter 20) are coupled via phosphofructokinase, because citrate, an intermediate in the citric acid cycle, is an allosteric inhibitor of phosphofructokinase. When the citric acid cycle reaches saturation, glycolysis (which feeds the citric acid cycle under aerobic conditions) slows down. The citric acid cycle directs electrons into the electron transport chain (for the purpose of ATP synthesis in oxidative phosphorylation) and also provides precursor molecules for biosynthetic pathways. Inhibition of glycolysis by citrate ensures that glucose will not be committed to these activities if the citric acid cycle is already saturated. 

In 1937 Krebs found that citrate could be formed in muscle suspensions if oxaloacetate and either pyruvate or acetate were added. He saw that he now had a cycle, not a simple pathway, and that addition of any of the intermediates could generate all of the others. The existence of a cycle, together with the entry of pyruvate into the cycle in the synthesis of citrate, provided a clear explanation for the accelerating properties of succinate, fumarate, and malate. If all these intermediates led to oxaloacetate, which combined with pyruvate from glycolysis, they could stimulate the oxidation of many substances besides themselves. (Kreb s conceptual leap to a cycle was not his first. Together with medical student Kurt Henseleit, he had already elucidated the details of the urea cycle in 1932.) The complete tricarboxylic acid (Krebs) cycle, as it is now understood, is shown in Figure 20.4. 

Citrate is isomerized to isocitrate by aconitase in a two-step process involving aconitate as an intermediate (Figure 20.7). In this reaction, the elements... 

It has often been questioned whether the rates and kinetics of purified enzymes, determined in very dilute solutions with high concentrations of their substrates, but not always of their cofactors, can be extrapolated to the conditions prevailing in the matrix. Much of the mitochondrial water will be bound to protein by hydrogen bonds and electrostatically, but there is also a pool of free water which may only be a fraction of the total water (Gitomer, 1987). The molar concentrations of intermediates of the citrate cycle and of p-oxidation are very low, usually less than those of most enzymes (Srere, 1987 Watmough et al., 1989 Sumegi et al., 1991). The extent to which cofactors and intermediates bind specifically or nonspecifically to enzymes is not known. It is therefore difficult to estimate concentration of these... 

Phosphofructokinase (PFK) is a key regulatory enzyme of glycolysis that catalyzes the conversion of fructose-6-phosphate to fructose-1,6-diphosphate. The active PFK enzyme is a homo- or heterotetrameric enzyme with a molecular weight of 340,000. Three types of subunits, muscle type (M), liver type (L), and fibroblast (F) or platelet (P) type, exist in human tissues. Human muscle and liver PFKs consist of homotetramers (M4 and L4), whereas red blood cell PFK consists of five tetramers (M4, M3L, M2L2, ML3, and L4). Each isoform is unique with respect to affinity for the substrate fructose-6-phosphate and ATP and modulation by effectors such as citrate, ATP, cAMP, and fructose-2,6-diphosphate. M-type PFK has greater affinity for fructose-6-phosphate than the other isozymes. AMP and fructose-2,6-diphosphate facilitate fructose-6-phosphate binding mainly of L-type PFK, whereas P-type PFK has intermediate properties. 

Lever Brothers, since it had to decide how to obtain the sodium citrate, had another host of alternatives to consider. It could produce or buy the product. If it chose to produce the builder, it could purchase the process from another firm or it could develop its own process. It could make the product from basic raw materials or from intermediate compounds. If it decided to let some other firm be the producer, it could buy the material on the open market or enter into a long-term agreement with another company. It might even do both by forming a joint company, such as Dow Coming, that would manufacture the builder. It could even buy a company that was currently producing it. All these possibilities must be economically evaluated to determine the best course of action to take. 

At least two enzymes compete for acetyl-CoA - the citrate synthase and 3-ke-tothiolase. The affinities of these enzymes differ for acetyl-CoA (Table l),and at low concentrations of it the citrate synthase reaction tends to dominate, provided that the concentration of 2/H/ is not inhibiting. The fine regulation of the citrate synthases of various poly(3HB) accumulating bacteria has been studied [ 14, 47, 48]. They appear to be controlled by cellular energy status indicators (ATP, NADH, NADPH) and/or intermediates of the TCA cycle. The 3-ketothio-lase has also been investigated [10-14,49, 50]. This enzyme is, above all, inhibited by CoASH [10,14,49]. This important feature will be further considered below. 

Another method for the synthesis of stable metal nanoparticles involves first mixing the metal hydrosols and an ethanol solution of dodecylamine and then extracting the dodecylamine-stabilized metal nanoparticles into toluene. The ethanol, a water miscible and good solvent for dodecylamine, was used as an intermediate solvent to improve the interfacial contact between citrate-stabilized metal nanoparticles and alkylamine. The extraction of dodecylamine-stabilized metal... 

The need to achieve high yield in one-pot synthesis, coupled to the relative kinetic inertness of rhenium complex (e.g. compared to technetium) and the mild conditions required has led to the development of useful versatile rhenium(V) intermediates that can be quickly prepared in quantitative yield, and are metastable, i.e. kinetically labile enough to react rapidly with the final chelator, again in high yield. The most widely used ligands suitable for this purpose are polydentate hydroxycarboxylic acids such as glucoheptonate [116a], citrate (47), tartrate (48), and 2-hydroxyisobutyric acid (49) [159]. Examples are discussed elsewhere in this chapter. They are typically used in the presence of Sn(II) to reduce Re(VII) to Re(V), at moderately elevated temperature (50-100 °C) at pH 2-3 (acid pH promotes reduction of perrhenate, presumably by facilitat-... 

Intraperitoneal injection of 4-methylpyrazole to rats at 90 mg/kg BW, given 2 h prior to 1080 administration, offered partial protection against accumulations of citrate or fluorocitrate in the kidney (Feldwick et al. 1994). The antidotal effects of 4-methylpyrazole are attributed to its inhibition of NAD+-dependent alcohol dehydrogenase that converts l,3-difluoro-2-propanol to difluoro-acetone, an intermediate in the pathway of erythrofluorocitrate metabolism (Feldwick et al. 1994). A disadvantage of 4-methylpyrazole is that it needs to be administered before significant exposure to fluoroacetate. 

The first suggestion that substrates in carbohydrate oxidation might exert catalytic effects on the oxidation of other intermediates (cf.earlier demonstration of such action in the urea cycle by Krebs and Henseleit, 1932 see Chapter 6) arose from the work of Szent-Gyorgi (1936). He demonstrated that succinate and its 4C oxidation products catalytically stimulated the rate of respiration by muscle tissues. He also observed that reactions between the 4C intermediates were reversible and that if muscle was incubated with oxaloacetate, fumarate and malate made up 50-75% of the products, 2-oxoglutarate 10-25% and, significantly, 1-2% of the C was converted to citrate. These observations were... 

A final demonstration was that 4C intermediates gave rise to citric acid. This was shown by Krebs with oxaloacetate as substrate under anaerobic conditions so that oxidation was blocked and citrate levels built up. 

The consequent interpretation, accepted by Krebs in his review of the tricarboxylic acid cycle in 1943, was therefore that citric acid could not be an intermediate on the main path of the cycle, and that the product of the condensation between oxaloacetate and acetyl CoA would have to be isocitrate, which is asymmetric. This view prevailed between 1941 and 1948 when Ogston made the important suggestion that the embarrassment of the asymmetric treatment of citrate could be avoided if the acid was metabolized asymmetrically by the relevant enzymes, citrate synthase and aconitase. If the substrate was in contact with its enzyme at three or more positions a chiral center could be introduced. 

We should note at this point that the TCA cycle is more than just a means of producing NADH for oxidative phosphorylation. The pathway also provides a number of useful intermediates for other, often synthetic, pathways. For example, citrate is the starting substance for fat synthesis (Chapter 9) succinyl-CoA is required for haem production and 2-oxoglutarate and oxaloacetate in particular are involved with amino acid and pyrimidine metabolism. Pathways which have dual catabolic/anabolic functions are referred to as amphibolic . 

Notice that none of the intermediates of the citric add cyde appear in this reaction, not as reactants or as products. This emphasizes an important (and frequently misunderstood) point about the cycle. It does not represent a pathway for the net conversion of acetyl CoA to citrate, to malate, or to any other intermediate of the cyde. The only fate of acetyl CoA in this pathway is its oxidation to CO,. Therefore, the dtric acid cycle does not represent a pathway by which there can be net synthesis of glucose from acetyl CoA... 

In our ease the hydrogen eonsumption of the former deconvolution peak is always indicating a reduction exceeding the mere Co Co. At one hour of grinding time sample BOl shows a 17.5% eonversion to the metal, whieh first increases to 31% after two hours (sample B02) and then deereases regularity to 13.7% after 10 hours of milling (sample BIO). The citrate sample, with the lowest surface area (see Table 1), yields only 2.3% conversion to the metal. Obviously some Co must be aheady formed at this intermediate temperature, well below the seeond peak eorresponding to the complete Co Co reduction of the bulk cobalt. 

Aconitase [citrate(isocitrate) hydro-lyase, EC 4.2.1.3] is the second enzyme of the citric acid cycle, which plays a central role in metabolism for all aerobic organisms. This enzyme catalyzes a dehydration-rehydration reaction interconverting citrate and 2R,3S-isocitrate via the allylic intermediate ds-aconitate. 

Gawron et al. (13,14) determined the stereochemistry of natural isocitric acid by chemical means. The results require the rrons-addition of water across the cis-aconitate intermediate double bond to produce either citrate or 2R,3S-isodtrate. Mass and NMR analyses of isotopically labeled citrate and isocitrate in the early 1960 s (15-17), defined the stercospedficities of the dehydration steps. These results led Gawron to propose the binding of cis-aconitate to the active site in two orientations differing by a 180° rotation about the double bond, as shown in Equation 2. This allows for the protonation by a base (-BH) and hydroxylation of the double bond to occur on aconitase at single, separate loci for the formation of either citrate or isocitrate. 

---